Zurcher Kantonalbank (Zurich Cantonalbank) - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 60 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$14,000
-36.4%
12,7000.0%0.00%
Q4 2018$22,000
-70.3%
12,7000.0%0.00%
-100.0%
Q3 2018$74,000
+37.0%
12,7000.0%0.00%
Q2 2018$54,000
-28.0%
12,7000.0%0.00%
-100.0%
Q1 2018$75,000
-3.8%
12,700
-24.4%
0.00%0.0%
Q4 2017$78,000
-15.2%
16,8000.0%0.00%0.0%
Q3 2017$92,00016,8000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders